Gambling on Clinical Trials @checkrare
Gambling on Clinical Trials  @checkrare
Uploaded October 2026 | Updated November 2026, 13 hours ago
In this episode, we discuss gambling on clinical trials, the FDA approval of a new formulation of Sjögren’s disease treatment, and an approval in IgA nephropathy.

Produced by CheckRare.

Explore additional CME activities, physician interviews, podcasts, and rare disease resources at CheckRare.com. Subscribe to the CheckRare Podcast Network for the latest rare disease education, expert interviews, and weekly news.

Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.
Gambling on Clinical TrialsMolecular Changes Associated With Teprotumumab Treatment in Thyroid Eye DiseaseMiv-cel Shows Durable Results in Stiff Person Syndrome and Myasthenia GravisNarcolepsy Awareness MonthFirst-Line Therapy Approved for Rare Lung Cancer  Safety and Efficacy of Kygevvi in Thymidine Kinase 2 DeficiencyPredicting Treatment Response Outcomes With Proteomic and Machine Learning Analyses in MGDiagnostic Delay in Endocrine DisordersGetting a Rare Disease Drug Approved Is Only Half the Battle | The CheckRare Brief Ep 4Gambling on Clinical TrialsAugust Is SMA Awareness MonthA Patient’s Journey With Essential Thrombocythemia and Polycythemia Vera
CheckRare |

Gambling on Clinical Trials

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER